Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 22954726)

1.

Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Ni H, Skogen B.

Curr Opin Hematol. 2012 Nov;19(6):469-74. doi: 10.1097/MOH.0b013e328358f86c. Review.

PMID:
22954726
2.

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H.

Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17.

PMID:
22251227
3.

Mechanisms and prevention of alloimmunization in pregnancy.

Kjeldsen-Kragh J, Skogen B.

Obstet Gynecol Surv. 2013 Jul;68(7):526-32. doi: 10.1097/OGX.0b013e3182947ce4. Review.

PMID:
23803755
4.

Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.

Socher I, Andrei-Selmer C, Bein G, Kroll H, Santoso S.

Transfusion. 2009 May;49(5):943-52. doi: 10.1111/j.1537-2995.2008.02065.x. Epub 2009 Jan 21.

PMID:
19175553
5.

[PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].

Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E.

Ginekol Pol. 2015 Jan;86(1):62-6. Polish.

PMID:
25775877
6.

Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.

Salomon O, Rosenberg N.

Br J Haematol. 2013 Aug;162(3):304-12. doi: 10.1111/bjh.12372. Epub 2013 May 14. Review.

PMID:
23672281
7.

Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.

Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S.

Transfusion. 2011 Nov;51(11):2455-61. doi: 10.1111/j.1537-2995.2011.03171.x. Epub 2011 May 12.

PMID:
21564107
8.

Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.

Bakchoul T, Greinacher A, Sachs UJ, Krautwurst A, Renz H, Harb H, Bein G, Newman PJ, Santoso S.

Blood. 2013 Jul 18;122(3):321-7. doi: 10.1182/blood-2012-11-468561. Epub 2013 May 3.

9.

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.

Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2.

10.
11.

Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.

Loewenthal R, Rosenberg N, Kalt R, Dardik R, Landau M, Yahalom V, Avishai O, Frenkel O, Gazit E, Steinberg DM, Lipitz S, Salomon O.

Transfusion. 2013 Feb;53(2):344-52. doi: 10.1111/j.1537-2995.2012.03734.x. Epub 2012 Jun 7.

PMID:
22671039
12.

The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.

Bakchoul T, Bertrand G, Krautwurst A, Kroll H, Bein G, Sachs UJ, Santoso S, Kaplan C.

Transfusion. 2013 Sep;53(9):2078-85. doi: 10.1111/trf.12051. Epub 2012 Dec 24.

PMID:
23278334
13.

Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a.

Kroll H, Penke G, Santoso S.

Thromb Haemost. 2005 Dec;94(6):1224-9.

PMID:
16411398
14.

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13.

PMID:
21895612
15.

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.

Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, Zdravic D, Vadasz B, Li C, Piran S, Marshall A, Zhu G, Tiller H, Killie MK, Boyd S, Leong-Poi H, Wen XY, Skogen B, Adamson SL, Freedman J, Ni H.

J Clin Invest. 2015 Apr;125(4):1545-56. doi: 10.1172/JCI77820. Epub 2015 Mar 16.

16.

Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.

Husebekk A, El Ekiaby M, Gorgy G, Killie MK, Uhlin-Hansen C, Salma W, Navarrete C, El Afandi M, Skogen B, Ahlen MT.

Transfus Apher Sci. 2012 Dec;47(3):277-82. doi: 10.1016/j.transci.2012.04.001. Epub 2012 May 27.

PMID:
22640833
17.

Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.

Ghevaert C, Wilcox DA, Fang J, Armour KL, Clark MR, Ouwehand WH, Williamson LM.

J Clin Invest. 2008 Aug;118(8):2929-38. doi: 10.1172/JCI34708.

18.

Would it be possible to prevent HPA-1a alloimmunization to reduce the incidence of fetal and neonatal alloimmune thrombocytopenia?

Kumpel BM.

Transfusion. 2012 Jul;52(7):1393-7. doi: 10.1111/j.1537-2995.2012.03700.x. No abstract available.

PMID:
22780891
19.

Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.

Socher I, Zwingel C, Santoso S, Kroll H.

Transfusion. 2008 Mar;48(3):463-72. Epub 2007 Dec 7.

PMID:
18067506
20.

Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.

Smith GA, Rankin A, Riddle C, Cheetham-Wilkinson C, Ranasinghe E, Ouwehand WH, Watkins NA.

Vox Sang. 2007 Nov;93(4):325-30.

PMID:
18070277
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk